There is a formula to convert murine dosages to human dosages. I'm sure Dr. Sinclair is very aware that to reproduce similar results in humans that he got in mice you have to use a certain dosage. That said, the first trial is a small trial to check the safety of the drug, so they could be trying the max dose for that purpose. Remember, that Sinclair and his family have been on this for quite a while now and I'm sure have had many blood tests to check the NAD+ levels and the other parameters.
I agree with you Brenner's presentation skills are very lacking.
The 2016 long term study says the 100mg/kg a day was better than 300mg/kg a day for some parameters and not as effective at others.
They say the 100mg/kg a day equals 560mg a day for humans, which maybe why Sinclair says 500mg a day.
The 30 day study for safety that Sinclair mentions isn't posted on clinical trials.
Anyone know if he was talking about the Japanese study that was supposed to start late last year or what?
This one is a different study:
https://clinicaltria...cond=nmn&rank=1
8 weeks of supplementation at 250mg a day, then following the subject for 2 years to judge the long term effects.
"This study is is looking at the effect of the dietary supplement "Nicotinamide mononucleotide" (NMN) on key cardiovascular and metabolic functions, specifically those that are important risk factors for diabetes and cardiovascular disease. Accordingly, the investigators will evaluate the effect of NMN on how well (a) the hormone insulin works to control blood sugar, (b) the body produces insulin, and © blood vessels dilate (get wider). The investigators will also look at the effects of NMN on blood lipids; body fat and liver fat; and other blood, fat tissue and muscle tissue markers of cardiovascular (heart) and metabolic health. Data from studies conducted in rodents have shown that NMN supplementation has beneficial effects on cardiovascular and metabolic health, but this has not yet been studied in people."
Edited by able, 03 November 2017 - 06:18 PM.